Drug Does Not Stall Memory Loss during Early Onset of Alzheimer’s

Mematime is an approved drug for Alzheimer’s patients According to a new study, Mematime will not assist patients to reduce the loss of memory and other cognitive functions during the early onset of Alzheimer’s disease. The drug has been approved by the United States Food and Drug Administration authorities for using in patients who are Read more